Syncona Investor Relations Material
Latest events
H2 2024
Syncona
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Syncona Limited
Access all reports
Syncona Limited is a closed-ended investment company based in Guernsey, specializing in the life sciences sector. The company's operations focus on founding, building, and funding companies to create a diversified portfolio of 20-25 globally leading healthcare companies.Syncona invests in a range of life sciences companies, including those working in gene therapy, cell therapy, biologics, and small molecule fields. Syncona is headquartered in Saint Peter Port, Guernsey, and its shares are listed on the London Stock Exchange.
Key slides for Syncona Limited
H2 2024
Syncona Limited
H2 2024
Syncona Limited
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
SYNC
Country
🇬🇧 United Kingdom